Pfizer Inc. (PFE)
Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises
Starboard took aim at Pfizer in another blow Tuesday, saying the company has failed to deliver on what it called the "best pipeline" ever.
Activist hedge fund Starboard met with Pfizer last week. Here's what went down.
Activist hedge fund Starboard has taken a stake in drug giant Pfizer. Starboard execs met with company officials last week to outline their complaints.
Pfizer (PFE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Starboard Value CEO Jeff Smith: Pfizer needs to do a better job disciplining itself on investments
Jeff Smith, Starboard Value CEO, joins CNBC's 'Squawk on the Street' to discuss how he sees Pfizer going forward, potential for growth in Kenvue, and more.
Do Billionaires Israel Englander and Ken Griffin Know Something? Each Just Bought This Plagued Value Stock.
Hedge funds managed by Israel Englander and Ken Griffin both scooped up shares in a troubled pharmaceutical stock last quarter.
Starboard Makes Its Case to Shake-Up Pfizer and Kenvue
Starboard has a $1 billion stake in Pfizer and an unknown but "sizable" stake in Kenvue, according to earlier media reports.
Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to Note
Pfizer (PFE) reachead $28.93 at the closing of the latest trading day, reflecting a -0.99% change compared to its last close.
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
Income investors have both good and not-so-good options in the healthcare sector.
Pfizer: Activists Clouding A Promising Picture
Pfizer's deep valuation and large dividend yield make it an attractive investment, despite potential distractions from activist investors. The focus should remain on existing cost realignment plans and pipeline investments to ensure positive financial returns for shareholders. The stock only trades at 10x forward EPS targets.
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why I'm Considering Leaning Heavily Into Pfizer
Pfizer's high dividend yield and robust pipeline could offer significant returns for patient investors.
How to play biotech stocks: Johnson & Johnson, Pfizer
Goldman Sachs senior biotechnology analyst in global investment research Chris Shibutani joins Market Domination Hosts Julie Hyman and Josh Lipton to break down how to play biotech and pharmaceutical stocks. Johnson & Johnson reports earnings on Tuesday, which Shibutani says “typically kicks off earnings season for healthcare, but also for the large-cap pharmas.
